INTUITIVE SURGICAL INC

ISRG

INTUITIVE SURGICAL INC

ISRG

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-12Shares Purchased (TTM):0Shares Sold (TTM):178,481

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:269,113,793Shares Outstanding:354,900,000Institutional Ownership Pct.:75.83%

Earnings Market Reaction:

Filing Date:2026-07-21Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

EW STE ZBH ALGN MSA ESTA

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	2,760	2,007	3,368	2,807	3,403	2,574	2,027	2,413	3,037	2,840	2,750	3,602
Marketable Securities Current	2,456	2,511	2,567	2,102	1,923	1,938	1,986	1,818	1,721	1,961	2,473	2,874
Accounts Receivable Net Current	1,673	1,596	1,527	1,260	1,269	1,222	1,225	1,153	1,109	1,128	1,130	963
Inventory Net	2,029	1,945	1,840	1,782	1,667	1,554	1,487	1,482	1,384	1,299	1,221	1,148
Prepaid Expense And Other Assets Current	625	752	477	575	483	371	385	349	404	405	314	317
Assets Current	9,543	8,810	9,780	8,525	8,746	7,658	7,111	7,216	7,654	7,633	7,888	8,903
Property Plant And Equipment Net	5,552	5,448	5,342	5,151	4,985	4,799	4,647	4,433	4,117	3,800	3,538	3,077
Marketable Securities Noncurrent	3,409	3,462	3,099	3,524	4,206	4,590	4,819	4,080	2,926	2,523	2,120	1,045
Deferred Income Tax Assets Net	652	684	1,019	979	1,070	1,039	1,045	997	947	918	911	701
Goodwill	581	613	370	348	349	348	348	348	348	348	349	348
Assets	20,877	20,111	20,459	19,352	20,163	19,220	18,743	17,743	16,650	15,828	15,442	14,713
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	277	333	255	291	267	276	193	219	194	194	189	196
Employee Related Liabilities Current	426	371	648	456	421	310	536	378	321	238	436	375
Deferred Revenue Current	549	560	507	491	500	496	469	426	434	438	446	395
Other Liabilities Current	671	648	596	565	505	456	548	655	538	505	588	711
Liabilities Current	1,923	1,911	2,006	1,803	1,693	1,538	1,745	1,677	1,488	1,375	1,659	1,676
Liabilities Other Than Longterm Debt Noncurrent	656	603	511	507	518	475	468	389	366	407	386	413
Liabilities	2,579	2,514	2,517	2,310	2,210	2,013	2,214	2,066	1,853	1,782	2,044	2,089
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	11,325	11,060	10,769	10,479	10,237	9,994	9,681	9,440	9,150	8,903	8,576	8,386
Retained Earnings Accumulated Deficit	6,837	6,398	7,012	6,424	7,606	7,139	6,803	6,130	5,582	5,068	4,743	4,209
Accumulated Other Comprehensive Income Loss Net Of…	6	17	43	27	3	-27	-51	13	-24	-9	-12	-57
Stockholders Equity	18,298	17,597	17,824	16,930	17,953	17,208	16,530	15,678	14,797	14,046	13,308	12,539
Minority Interest	129	123	118	112	107	101	96	94	88	84	90	85
Liabilities And Stockholders Equity	20,877	20,111	20,459	19,352	20,163	19,220	18,743	17,743	16,650	15,828	15,442	14,713
Allowance For Doubtful Accounts Receivable Current	-	-	30	-	-	-	31	-	-	-	27	-
Preferred Stock Shares Authorized	3	3	3	3	3	3	3	3	3	3	3	3
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	600	600	600	600	600	600	600	600	600	600	600	600
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Issued	354	354	355	355	358	358	357	356	355	355	352	352
Shares Outstanding	354	354	355	355	358	358	357	356	355	355	352	352

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-12.92%	-15.00%	-15.89%	-	-	-	-	-	-	-	-	-
2025	15.51%	4.97%	4.95%	-4.32%	-10.41%	-14.42%	4.27%	2.90%	11.23%	5.14%	-5.48%	0.70%
2024	5.56%	14.00%	21.13%	1.85%	3.69%	5.92%	2.94%	5.61%	2.71%	3.48%	-13.88%	-15.59%
2023	-	-	-	-11.62%	-8.66%	-15.58%	3.96%	16.30%	20.83%	3.05%	4.19%	-3.14%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Performance and Valuation Metrics

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.96	4.61	4.87	4.73	5.17	4.98	4.07	4.30	5.15	5.55	4.76	5.31
Quick Ratio	3.58	3.20	3.72	3.42	3.90	3.73	3.00	3.21	3.94	4.31	3.83	4.44
Working Capital	7.62B	6.90B	7.77B	6.72B	7.05B	6.12B	5.37B	5.54B	6.17B	6.26B	6.23B	7.23B
Leverage & Debt
Debt to Equity	0.14	0.14	0.14	0.14	0.12	0.12	0.13	0.13	0.13	0.13	0.15	0.17
Debt Ratio	0.12	0.12	0.12	0.12	0.11	0.10	0.12	0.12	0.11	0.11	0.13	0.14
Efficiency & Turnover
Asset Turnover TTM	0.54	0.54	0.51	0.52	0.50	0.50	0.49	0.48	0.50	0.51	0.50	0.49
Days Sales Outstanding TTM	48.66	48.58	49.91	45.81	47.46	49.20	51.47	49.08	48.52	51.20	53.09	48.28
Receivables Turnover TTM	7.50	7.51	7.31	7.97	7.69	7.42	7.09	7.44	7.52	7.13	6.88	7.56
Per Share Metrics
Diluted EPS TTM	8.77	8.27	7.87	7.60	7.16	6.80	6.42	6.24	5.86	5.57	5.08	4.25
Free Cash Flow Per Share TTM	9.10	7.99	6.98	6.37	5.56	4.88	3.67	1.65	1.18	1.69	2.13	3.57
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.02	0.02	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	66.68%	66.29%	66.00%	66.38%	66.61%	67.09%	67.46%	66.98%	66.86%	66.43%	66.39%	66.61%
Operating Profit Margin TTM	31.28%	30.45%	29.27%	29.30%	28.80%	28.20%	28.12%	26.24%	25.79%	25.26%	24.80%	24.66%
Net Profit Margin TTM	28.40%	28.10%	28.38%	28.61%	28.49%	28.44%	27.81%	28.78%	27.93%	27.46%	25.51%	22.20%
Growth Metrics
Net Revenue Growth (1Y)	20.66%	21.43%	20.51%	22.18%	20.77%	19.08%	17.24%	14.83%	13.62%	13.81%	14.49%	11.98%
Net Income Growth (1Y)	20.25%	19.96%	22.97%	21.45%	23.21%	23.37%	27.80%	48.85%	47.87%	53.16%	37.43%	9.18%
EPS Growth (1Y)	21.75%	20.84%	22.38%	21.17%	22.01%	21.98%	26.37%	47.13%	46.17%	51.73%	39.20%	10.30%
Valuation Metrics
P/E TTM	44.94	55.02	70.78	58.00	74.76	71.43	79.82	77.20	74.67	70.21	65.20	67.58
P/B TTM	7.70	9.30	11.27	9.42	10.85	10.29	11.22	11.15	10.67	10.04	8.84	8.20
P/S TTM	12.76	15.46	20.08	16.59	21.30	20.32	22.20	22.22	20.85	19.28	16.63	15.01
Market Cap	140.82B	163.61B	202.13B	159.48B	194.81B	177.06B	185.40B	174.79B	157.92B	141.08B	118.48B	102.80B
Enterprise Value	138.01B	161.55B	198.73B	156.63B	191.37B	174.44B	183.34B	172.35B	154.85B	138.21B	115.71B	99.18B
Calculated Values
Free Cash Flow TTM	3.22B	2.83B	2.49B	2.27B	1.99B	1.75B	1.30B	586.00M	419.50M	595.80M	749.60M	1.26B
Net Debt	-2.81B	-2.05B	-3.41B	-2.85B	-3.45B	-2.62B	-2.06B	-2.45B	-3.07B	-2.87B	-2.77B	-3.62B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-06-12Sale

Owner: Brosius, Mark

Title: EVP & Chief Mfg and Supply Cha

Shares: 25

Price/Share: $414.13

Value: $10,353.25

Shares Owned: 1,406

Relationship: Officer

Ownership: Direct

2026-06-10Sale

Owner: Brosius, Mark

Title: EVP & Chief Mfg and Supply Cha

Shares: 23

Price/Share: $424.14

Value: $9,755.22

Shares Owned: 1,454

Relationship: Officer

Ownership: Direct

2026-06-10Sale

Owner: Loeb, Gary

Title: EVP & Chief Legal and Complian

Shares: 400

Price/Share: $424.14

Value: $169,656.00

Shares Owned: 5,720

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Jeddi, Iman

Title: SVP & GM da Vinci Platforms &

Shares: 5,625

Price/Share: $420.55

Value: $2,365,593.75

Shares Owned: 6,463

Relationship: Officer

Ownership: Direct

2026-05-22Sale

Owner: Brosius, Mark

Title: EVP & Chief Mfg and Supply Cha

Shares: 18

Price/Share: $439.80

Value: $7,916.40

Shares Owned: 1,523

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Brosius, Mark	Officer	EVP & Chief Mfg and Supply Cha	Direct	Sale	25	414.13	$10,353.25	1,406	4
2026-06-10	Brosius, Mark	Officer	EVP & Chief Mfg and Supply Cha	Direct	Sale	23	424.14	$9,755.22	1,454	4
2026-06-10	Loeb, Gary	Officer	EVP & Chief Legal and Complian	Direct	Sale	400	424.14	$169,656.00	5,720	4
2026-06-01	Jeddi, Iman	Officer	SVP & GM da Vinci Platforms &	Direct	Sale	5,625	420.55	$2,365,593.75	6,463	4
2026-05-22	Brosius, Mark	Officer	EVP & Chief Mfg and Supply Cha	Direct	Sale	18	439.80	$7,916.40	1,523	4
2026-05-20	Brosius, Mark	Officer	EVP & Chief Mfg and Supply Cha	Direct	Sale	18	440.38	$7,926.84	1,559	4
2026-05-11	Loeb, Gary	Officer	EVP & Chief Legal and Complian	Direct	Sale	400	446.95	$178,780.00	6,120	4
2026-04-29	Ladd, Amy L	Director	-	Direct	Sale	119	463.50	$55,156.50	120	4
2026-03-10	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	105	493.95	$51,864.75	0	4
2026-03-09	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	645	485.01	$312,831.45	1,613	4
2026-03-05	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	648	495.20	$320,889.60	2,906	4
2026-03-03	Widman, Fredrik	Officer	VP Corporate Controller	Direct	Sale	118	487.18	$57,487.24	1,026	4
2026-03-03	Curet, Myriam	Officer	EVP & Chief Medical Officer	Indirect	Sale	4,728	487.18	$2,303,387.04	409	4
2026-02-27	Wadors, Patricia L	Officer	SVP Chief Human Resources Offi	Direct	Sale	220	499.71	$109,936.20	0	4
2026-02-27	Curet, Myriam	Officer	EVP & Chief Medical Officer	Indirect	Sale	2,345	499.71	$1,171,819.95	409	4
2026-02-11	Widman, Fredrik	Officer	VP Corporate Controller	Direct	Sale	133	494.96	$65,829.68	660	4
2026-02-11	Curet, Myriam	Officer	EVP & Chief Medical Officer	Indirect	Sale	421	494.96	$208,378.16	409	4
2026-01-29	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	126	520.02	$65,522.52	0	4
2026-01-27	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	230	532.61	$122,500.30	0	4
2026-01-27	Guthart, Gary S	Director	-	Direct	Sale	24,500	530.10	$12,987,450.00	3,694	4
2025-12-15	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	464	548.49	$254,499.36	443	4
2025-12-15	Brosius, Mark	Officer	See Remarks	Direct	Sale	464	548.49	$254,499.36	131	4
2025-12-12	Brosius, Mark	Officer	See Remarks	Direct	Sale	312	547.36	$170,776.32	595	4/A
2025-12-10	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	104	559.90	$58,229.60	0	4
2025-12-01	Guthart, Gary S	Director,Officer	Executive Chair of the Board o	Direct	Sale	22,806	570.89	$13,019,717.34	2,694	4
2025-12-01	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	125	568.99	$71,123.75	0	4
2025-11-12	Charlton, Henry L	Officer	EVP & Chief Commercial and Mkt	Direct	Sale	13,731	580.00	$7,963,980.00	3,056	4
2025-11-12	Barratt, Craig H	Director	-	Direct	Sale	750	580.00	$435,000.00	0	4
2025-11-10	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	105	560.00	$58,800.00	0	4
2025-11-10	Miller, Brian Edward	Officer	EVP & Chief Digital Officer	Direct	Sale	3,500	575.00	$2,012,500.00	5,758	4
2025-11-05	Widman, Fredrik	Officer	VP Corporate Controller	Direct	Sale	2,067	550.00	$1,136,850.00	473	4
2025-10-29	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	125	543.00	$67,875.00	0	4
2025-10-24	Barratt, Craig H	Director	-	Direct	Sale	2,193	548.01	$1,201,785.93	0	4
2025-10-24	Guthart, Gary S	Director,Officer	Executive Chair of the Board o	Direct	Sale	28,800	547.56	$15,769,728.00	27,027	4
2025-10-24	Rosa, David J.	Director,Officer	Chief Executive Officer (CEO)	Direct	Sale	24,500	547.55	$13,414,975.00	234,256	4
2025-09-04	Ladd, Amy L	Director	-	Direct	Sale	335	440.69	$147,631.15	739	4
2025-08-29	Guthart, Gary S	Director,Officer	Executive Chair of the Board o	Direct	Sale	29,360	472.49	$13,872,306.40	19,827	4
2025-07-28	Guthart, Gary S	Director,Officer	Executive Chair of the Board o	Direct	Sale	7,893	498.64	$3,935,765.52	13,187	4
2025-07-25	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	4,500	492.48	$2,216,160.00	353	4
2025-06-06	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	216	563.11	$121,631.76	907	4
2025-06-04	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	215	552.07	$118,695.05	1,338	4
2025-05-16	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	20	563.81	$11,276.20	1,983	4
2025-05-14	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	22	563.00	$12,386.00	2,025	4
2025-05-02	Samath, Jamie	Officer	See Remarks	Direct	Sale	915	527.95	$483,074.25	7,162	4
2025-05-01	Nachtsheim, Jami K	Director	-	Direct	Sale	2,400	520.00	$1,248,000.00	6,371	4
2025-04-30	Ladd, Amy L	Director	-	Direct	Sale	8,776	505.55	$4,436,706.80	1,410	4
2025-04-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	188	512.90	$96,425.20	5,224	4
2025-04-25	Loeb, Gary	Officer	EVP & Chief Legal and Complian	Direct	Sale	1,700	513.18	$872,406.00	2,245	4
2025-04-25	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	4,000	513.18	$2,052,720.00	353	4
2025-03-13	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	11,545	498.87	$5,759,454.15	5,224	4
2025-03-12	Miller, Brian Edward	Officer	EVP & Chief Digital Officer	Direct	Sale	4,000	512.06	$2,048,240.00	5,758	4
2025-03-07	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	489	533.18	$260,725.02	2,091	4
2025-03-06	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	492	558.95	$275,003.40	2,580	4
2025-03-05	Rosa, David J.	Director,Officer	President	Direct	Sale	16,509	557.53	$9,204,262.77	225,438	4
2025-03-03	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	3,031	577.30	$1,749,796.30	353	4
2025-03-03	Widman, Fredrik	Officer	VP Corporate Controller	Direct	Sale	810	573.78	$464,761.80	473	4
2025-03-03	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	492	573.78	$282,299.76	4,056	4
2025-02-28	Samath, Jamie	Officer	EVP & CFO & Enterprise Technol	Direct	Sale	188	566.94	$106,584.72	7,162	4
2025-02-27	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	2,401	581.00	$1,394,981.00	353	4
2025-02-26	Samath, Jamie	Officer	EVP & CFO & Enterprise Technol	Direct	Sale	108	570.85	$61,651.80	4,890	4
2025-02-12	Loeb, Gary	Officer	EVP & Chief Legal and Complian	Direct	Sale	2,600	583.79	$1,517,854.00	3,176	4
2025-02-11	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	408	589.75	$240,618.00	353	4
2025-02-10	Samath, Jamie	Officer	EVP & CFO & Enterprise Technol	Direct	Sale	269	590.00	$158,710.00	3,282	4
2025-01-29	Samath, Jamie	Officer	EVP & CFO & Enterprise Technol	Direct	Sale	94	571.11	$53,684.34	2,630	4
2025-01-28	Johnson, Amal M	Director	-	Direct	Sale	4,635	566.60	$2,626,191.00	12,275	4
2025-01-28	Ladd, Amy L	Director	-	Direct	Sale	150	566.60	$84,990.00	671	4
2024-12-10	Samath, Jamie	Officer	CFO and Head of Business Techn	Direct	Sale	270	540.16	$145,843.20	8,757	4
2024-11-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	376	539.00	$202,664.00	5,506	4
2024-11-29	Samath, Jamie	Officer	CFO and Head of Business Techn	Direct	Sale	188	539.00	$101,332.00	8,757	4
2024-11-26	Samath, Jamie	Officer	CFO and Head of Business Techn	Direct	Sale	108	542.06	$58,542.48	8,757	4
2024-11-26	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	396	542.06	$214,655.76	5,506	4
2024-11-12	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	13,466	535.96	$7,217,237.36	298	4
2024-11-11	Samath, Jamie	Officer	See Remarks	Direct	Sale	269	539.89	$145,230.41	8,757	4
2024-11-11	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	239	539.89	$129,033.71	5,506	4
2024-10-30	Guthart, Gary S	Director,Officer	CEO	Direct	Sale	18,151	511.63	$9,286,596.13	24,219	4
2024-10-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	188	506.52	$95,225.76	5,506	4
2024-10-28	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	22	513.66	$11,300.52	185	4
2024-10-24	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	22	510.79	$11,237.38	229	4
2024-10-22	Miller, Brian Edward	Officer	EVP & Chief Digital Officer	Direct	Sale	2,553	515.00	$1,314,795.00	7,066	4
2024-09-13	Ladd, Amy L	Director	-	Direct	Sale	450	490.28	$220,626.00	821	4
2024-09-12	Brosius, Mark	Officer	See Remarks	Direct	Sale	2,115	491.91	$1,040,389.65	295	4
2024-09-10	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	238	477.50	$113,645.00	5,506	4
2024-09-09	Loeb, Gary	Officer	General Counsel	Direct	Sale	300	475.00	$142,500.00	1,595	4
2024-08-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	188	482.21	$90,655.48	5,506	4
2024-08-26	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	396	486.88	$192,804.48	5,506	4
2024-08-23	Charlton, Henry L	Officer	SVP & Chief Commercial and Mkt	Direct	Sale	40,243	486.84	$19,591,902.12	3,001	4
2024-08-12	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	240	464.76	$111,542.40	5,506	4
2024-08-01	Johnson, Amal M	Director	-	Direct	Sale	2,943	443.30	$1,304,631.90	12,275	4
2024-07-30	Guthart, Gary S	Director,Officer	CEO	Direct	Sale	23,388	443.07	$10,362,521.16	17,170	4
2024-07-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	376	446.60	$167,921.60	5,506	4
2024-07-23	Barratt, Craig H	Director	-	Direct	Sale	1,400	458.13	$641,382.00	0	4
2024-07-23	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	2,818	458.13	$1,291,010.34	298	4
2024-06-12	Barratt, Craig H	Director	-	Direct	Sale	1,400	421.06	$589,484.00	0	4
2024-06-10	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	239	416.60	$99,567.40	5,506	4
2024-06-05	Barratt, Craig H	Director	-	Direct	Sale	1,400	411.00	$575,400.00	0	4
2024-06-03	Barratt, Craig H	Director	-	Direct	Sale	2,496	402.89	$1,005,613.44	0	4
2024-05-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	188	396.59	$74,558.92	5,506	4
2024-05-17	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	63	396.19	$24,959.97	295	4
2024-05-16	Miller, Brian Edward	Officer	EVP & Chief Digital Officer	Direct	Sale	2,553	400.00	$1,021,200.00	9,619	4
2024-05-15	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	175	387.22	$67,763.50	533	4
2024-05-13	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	284	389.16	$110,521.44	5,506	4
2024-05-03	Rubash, Mark J	Director	-	Direct	Sale	1,709	380.00	$649,420.00	16,051	4
2024-04-29	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	376	375.39	$141,146.64	5,507	4
2024-04-23	Levy, Alan J	Director	-	Direct	Sale	2,000	370.70	$741,400.00	25,319	4
2024-04-23	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	5,318	370.66	$1,971,169.88	298	4
2024-03-15	Widman, Fredrik	Officer	VP Corporate Controller	Direct	Sale	5,041	397.07	$2,001,629.87	110	4
2024-03-11	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	329	390.16	$128,362.64	5,507	4
2024-03-11	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	196	390.16	$76,471.36	1,058	4
2024-03-07	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	196	393.30	$77,086.80	1,450	4
2024-03-01	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	1,605	383.48	$615,485.40	298	4
2024-02-28	Mohr, Marshall	Officer	Executive VP Global Business S	Direct	Sale	108,790	385.08	$41,892,853.20	26,877	4
2024-02-27	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	843	386.46	$325,785.78	298	4
2024-02-16	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	32	378.29	$12,105.28	709	4
2024-02-13	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	30	375.51	$11,265.30	801	4
2024-02-12	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	481	386.09	$185,709.29	298	4
2024-02-07	Rosa, David J.	Officer	President	Direct	Sale	80,710	389.28	$31,418,788.80	163,399	4
2024-02-01	Brosius, Mark	Officer	SVP & Chief Mfg and Supply Cha	Direct	Sale	39	378.41	$14,757.99	448	4
2024-01-29	Guthart, Gary S	Director,Officer	CEO	Direct	Sale	24,325	376.06	$9,147,659.50	9,425	4
2024-01-26	Johnson, Amal M	Director	-	Direct	Sale	6,696	370.08	$2,478,055.68	11,706	4
2024-01-26	Levy, Alan J	Director	-	Direct	Sale	2,000	370.20	$740,400.00	25,319	4
2024-01-26	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	4,318	370.15	$1,598,307.70	189	4
2023-11-16	Johnson, Amal M	Director	-	Direct	Sale	9,567	300.00	$2,870,100.00	11,706	4
2023-11-16	Curet, Myriam	Officer	EVP & Chief Medical Officer	Direct	Sale	8,819	300.00	$2,645,700.00	189	4
2023-11-14	Levy, Alan J	Director	-	Direct	Sale	2,000	290.00	$580,000.00	25,319	4
2023-11-14	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	867	290.00	$251,430.00	7,259	4
2023-10-26	Guthart, Gary S	Director,Officer	CEO	Direct	Sale	27,385	260.11	$7,123,112.35	23,551	4
2023-10-24	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	1,110	272.95	$302,974.50	7,259	4
2023-09-14	Ladd, Amy L	Director	-	Direct	Sale	500	305.68	$152,840.00	702	4
2023-08-07	Levy, Alan J	Director	-	Direct	Sale	2,000	310.00	$620,000.00	25,319	4
2023-07-31	Guthart, Gary S	Director,Officer	CEO	Indirect	Sale	4,960	325.89	$1,616,414.40	32,320	4
2023-07-25	Desantis, Robert	Officer	EVP & Chief Strategy & Corp Op	Direct	Sale	2,535	323.13	$819,134.55	7,259	4
2023-06-14	Mohr, Marshall	Officer	Executive VP Global Business S	Direct	Sale	11,250	325.00	$3,656,250.00	24,136	4
2023-06-14	Barratt, Craig H	Director	-	Direct	Sale	1,567	322.78	$505,796.26	0	4
2023-06-14	Desantis, Robert	Officer	EVP & Chief Product Officer	Direct	Sale	2,443	325.00	$793,975.00	7,259	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

75.83%

Inst. Shares: 269,113,793

Shares Outstanding: 354,900,000

2025-12-31

77.84%

Inst. Shares: 277,811,485

Shares Outstanding: 356,900,000

2025-09-30

76.18%

Inst. Shares: 271,642,857

Shares Outstanding: 356,600,000

2025-06-30

77.64%

Inst. Shares: 278,333,229

Shares Outstanding: 358,500,000

2025-03-31

75.97%

Inst. Shares: 271,596,170

Shares Outstanding: 357,500,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	269,113,793	354,900,000	75.83%
2025-12-31	277,811,485	356,900,000	77.84%
2025-09-30	271,642,857	356,600,000	76.18%
2025-06-30	278,333,229	358,500,000	77.64%
2025-03-31	271,596,170	357,500,000	75.97%
2024-12-31	276,922,720	355,200,000	77.96%
2024-09-30	269,943,326	355,800,000	75.87%
2024-06-30	276,109,365	355,000,000	77.78%
2024-03-31	265,407,936	353,500,000	75.08%
2023-12-31	265,164,811	351,200,000	75.50%
2023-09-30	259,624,354	351,700,000	73.82%
2023-06-30	253,267,037	350,900,000	72.18%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

INTUITIVE SURGICAL INC (ISRG) — SEC Financial Statements & Analysis

INTUITIVE SURGICAL INC (ISRG) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. INTUITIVE SURGICAL INC trades on ISRG: Nasdaq as: ISRG. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INTUITIVE SURGICAL INC reported a 20.66% year-over-year revenue growth, a Gross Profit Margin of 66.68% (TTM), a Debt-to-Equity ratio of 0.14x, a Price-to-Sales (P/S) ratio of 12.76x (TTM), a Price-to-Book (P/B) ratio of 7.7 (TTM), at a market cap of $140.82B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 20.66%
Gross Profit Margin TTM: 66.68%
Debt To Equity: 0.14x
P/S TTM: 12.76x
P/B TTM: 7.7
Market Cap: $140.82B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is INTUITIVE SURGICAL INC in?

INTUITIVE SURGICAL INC (ISRG) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is ISRG's market cap?

INTUITIVE SURGICAL INC (ISRG) has a market capitalization of $140.82B as of 2026-06-30.

What is ISRG's P/E ratio?

INTUITIVE SURGICAL INC (ISRG)'s trailing twelve month P/E ratio is 44.94x as of 2026-06-30.

What exchange does ISRG trade on?

INTUITIVE SURGICAL INC (ISRG) trades on the ISRG: Nasdaq.

Where is INTUITIVE SURGICAL INC incorporated?

INTUITIVE SURGICAL INC is incorporated in DE.